Information about Shant Biotech
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0680.795.389

VAT liability
Yes
Established
07-09-2017
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Manufacture of basic pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Shant Biotech

2024 2023 2022 2021
Profit/Loss -153,611 -45 % -106,163 -42 % -74,783 -17 % -63,911
Equity -538,934 -40 % -385,323 -38 % -279,160 -37 % -204,377
Gross margin -147,705 -50 % -98,690 -67 % -59,105 -33 % -44,329

Publications from Shant Biotech

Date Publication
28-07-2025 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital, Shares - Resignations, Appointments (FR)
01-04-2025 Resignations, Appointments (FR)
11-09-2017 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Shant Biotech?
The VAT number of Shant Biotech is BE 0680.795.389.
Wat is the PEPPOL ID of Shant Biotech?
The PEPPOL ID of Shant Biotech is 0208:0680795389. Log in or start a free trial to see the full overview.
When was Shant Biotech founded?
Shant Biotech was founded on 07-09-2017.
What is the address of Shant Biotech?
The current registered office of Shant Biotech is located at Avenue Léon Champagne 2, 1480 Tubize.
When was the last time Shant Biotech filed their annual financial statements?
The most recent financial statements of Shant Biotech were filed on 28-08-2025.
How many employees does Shant Biotech have?
There are currently no employees working at Shant Biotech or no workforce information is available.
What is the annual turnover of Shant Biotech?
At the time of its most recent financial statements, Shant Biotech did not publish any turnover figures. Shant Biotech reported a gross margin of -€147,705.05.